Thoracic Surgery
Multicenter comparative accuracy trial: Dynamic contrast-enhanced CT vs. positron emission tomography CT to characterize solitary pulmonary nodules.
16 Mar, 2022 | 08:51h | UTCDownload: Full Report
Patient-centered care in thoracic surgery: a holistic approach—A review of the subjects of enhanced recovery after surgery, rehabilitation, pain management and patient-reported outcome measures in thoracic surgery.
15 Mar, 2022 | 08:16h | UTC
Review: Current surgical indications for non-small-cell lung cancer.
11 Mar, 2022 | 08:39h | UTCCurrent Surgical Indications for Non-Small-Cell Lung Cancer – Cancers
RCT: Role of thoracic ultrasonography in pleurodesis pathways for malignant pleural effusions.
8 Mar, 2022 | 08:28h | UTCRole of thoracic ultrasonography in pleurodesis pathways for malignant pleural effusions (SIMPLE): an open-label, randomised controlled trial – The Lancet Respiratory Medicine (link to abstract – $ for full-text)
Commentary on Twitter
Thoracic ultrasonography-guided pleurodesis in patients with malignant pleural effusions results in shorter hospital stay without reducing the success rate of the procedure at 3 monthshttps://t.co/hof4Rd2nUt
— K Pavithran (@drkpavithran) March 2, 2022
RCT: In patients with early-stage lung cancer, video-assisted thoracoscopic lobectomy is associated with better recovery of physical function at 5 weeks.
3 Mar, 2022 | 08:42h | UTCVideo-Assisted Thoracoscopic or Open Lobectomy in Early-Stage Lung Cancer – NEJM Evidence
Commentary on Twitter
For patients with early-stage #LungCancer, resection by video-assisted thoracoscopic surgery was superior to open resection with respect to postoperative recovery of physical function as shown in a randomized trial. @ekslim @RBandH #VATS #OncoAlert https://t.co/j23CgZp5U5 pic.twitter.com/UsIx3D8Zem
— NEJM Evidence (@NEJMEvidence) January 19, 2022
SEOM-GECP-GETTHI Clinical Guidelines for the treatment of patients with thymic epithelial tumors.
3 Mar, 2022 | 08:08h | UTC
Guideline Update: Timing of elective surgery and risk assessment after SARS-CoV-2 infection – “The guidance remains that patients should avoid elective surgery within 7 weeks of infection, unless the benefits of doing so exceed the risk of waiting”.
1 Mar, 2022 | 08:58h | UTCTiming of elective surgery and risk assessment after SARS-CoV-2 infection: an update – Anaesthesia
Related:
Guideline: SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery
BJS commission on surgery and perioperative care post-COVID-19.
ASA Guidance: Preoperative testing for COVID-19 is essential, regardless of vaccination.
Position statement: Perioperative management of post-COVID-19 surgical patients.
Surgery students ‘losing dexterity to stitch patients’.
21 Feb, 2022 | 09:24h | UTCSurgery students ‘losing dexterity to stitch patients’ – BBC
Malignant pleural effusions: a review of current guidelines and practices.
9 Feb, 2022 | 08:19h | UTCRelated: Meta-Analysis: Interventions for the Management of Malignant Pleural Effusions
Evaluation and management of traumatic pneumothorax: A Western Trauma Association critical decisions algorithm.
3 Feb, 2022 | 08:46h | UTC
RCT: Sugemalimab improves progression-free survival vs. placebo in patients with metastatic non-small-cell lung cancer.
1 Feb, 2022 | 08:25h | UTCSugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial – The Lancet Oncology (link to abstract – $ for full-text)
Related study: Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial – The Lancet Oncology (link to abstract – $ for full-text)
Commentaries:
Sugemalimab shows promise for locally advanced, metastatic NSCLC – Medicine Matters
Sugemalimab Boosts Outcomes in NSCLC – MedPage Today (free registration required)
Commentary on Twitter
In the phase III GEMSTONE-302 trial of chemo + sugemalimab or placebo in 479 with untreated advanced-stage NSCLC, mPFS was 9.0 vs 4.9 months (HR 0.48; P<0.0001); OS was 72.4% vs 62.0% at 12 months & 47.1% vs 38.1% at 24 months (HR 0.67, 95% CI 0.50–0.90): https://t.co/z6f00tqy8B
— NatureRevClinOncol (@NatRevClinOncol) January 19, 2022
Clinical characteristics and outcomes of patients with COVID-19–Associated Acute Respiratory Distress Syndrome who underwent lung transplant.
28 Jan, 2022 | 08:41h | UTC
M-A: Surgical management of rib fractures after blunt trauma.
28 Jan, 2022 | 08:02h | UTC
Cases of lung transplantation for Covid-19–related respiratory failure in the US were associated with a three-month survival of 95.6%.
27 Jan, 2022 | 10:00h | UTCCommentaries:
New data on COVID-19 lung transplants – Cedars-Sinai Medical Center
~7 Percent of Lung Transplants Due to COVID-19 Respiratory Failure – HealthDay
Comprehensive review of chest tube management.
27 Jan, 2022 | 09:40h | UTCComprehensive Review of Chest Tube Management – JAMA Surgery (free for a limited period)
Review: Evaluating the patient with a pulmonary nodule.
20 Jan, 2022 | 08:56h | UTCEvaluating the Patient With a Pulmonary Nodule: A Review – JAMA (free for a limited period)
Author Interview: Evaluation and Management of Patients With Pulmonary Nodules
ASCO Guideline: Management of stage III non–small-cell lung cancer.
18 Jan, 2022 | 09:12h | UTCManagement of Stage III Non–Small-Cell Lung Cancer: ASCO Guideline – Journal of Clinical Oncology
RCT: Postoperative radiotherapy (PORT) did not increase disease-free survival compared with no PORT in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement.
8 Jan, 2022 | 22:38h | UTCPostoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial – The Lancet Oncology (link to abstract – $ for full-text)
Commentaries:
Post-Operative Radiotherapy Not Tied to Better Disease-Free Survival in NSCLC – MedPage Today (free registration required)
Guideline: Prevention, diagnosis, and management of post-surgical mediastinitis in adults.
17 Dec, 2021 | 08:41h | UTC
Modern day management of a unilateral pleural effusion.
9 Dec, 2021 | 09:58h | UTCModern day management of a unilateral pleural effusion – Clinical Medicine Journal
Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
8 Dec, 2021 | 09:47h | UTC
The risk of postoperative complications following major elective surgery in active or resolved COVID-19 in the United States – Major, elective surgery 0–4 weeks after Covid-19 is associated with greatly increased risk of postoperative complications; surgery performed 4–8 weeks after infection is still associated with an increased risk of pneumonia.
7 Dec, 2021 | 10:23h | UTCRelated:
Guideline: SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery
ASA Guidance: Preoperative testing for COVID-19 is essential, regardless of vaccination.
Position statement: Perioperative management of post-COVID-19 surgical patients.
RCT: Small caliber 14-Fr percutaneous catheters (pigtail) were as effective as 28- to 32-Fr chest tubes in their ability to drain traumatic hemothorax with no difference in complications.
30 Nov, 2021 | 10:11h | UTCThe small (14 Fr) percutaneous catheter (P-CAT) versus large (28–32 Fr) open chest tube for traumatic hemothorax: A multicenter randomized clinical trial – Trauma and Acute Care Surgery (link to abstract – $ for full-text)
Screening for Lung Cancer: CHEST Guideline and Expert Panel Report.
28 Nov, 2021 | 21:22h | UTCExecutive Summary: Screening for Lung Cancer: Chest Guideline and Expert Panel Report
Full Guideline: Screening for Lung Cancer: CHEST Guideline and Expert Panel Report
News Release: CHEST releases expert guidelines for lung cancer screening – Elsevier
Related:
Commentary on Twitter
CHEST Guidelines and Expert Panel Report contains 16 evidence-based recommendations for the benefits, harms, and implementation of low-dose chest computed tomography (CT) screening. https://t.co/4mvjEOftQl #CHESTOnc #CHESTGuidelines #LungCancerAwarenessMonth pic.twitter.com/uyh9Pf0s5s
— CHEST® Journal (@journal_CHEST) November 23, 2021
Review and algorithm: Dysphagia aortica.
16 Nov, 2021 | 08:19h | UTCDysphagia aortica – European Surgery